BiotechTube
Home/Pipeline/Calnexin‑Ab‑Arth

Calnexin‑Ab‑Arth

Osteoarthritis / Rheumatoid arthritis

PreclinicalActive

Key Facts

Indication
Osteoarthritis / Rheumatoid arthritis
Phase
Preclinical
Status
Active
Company
Albatroz Therapeutics

About Albatroz Therapeutics

Innovative antibodies targeting Calnexin to protect extracellular matrix and treat cancer, arthritis, and IBD.

View full company profile

Therapeutic Areas

OncologyRheumatologyGastroenterology